Uzm. Dr. Sinemis Çelik

Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

Anadolu Kliniği Tıp Bilimleri Dergisi, 2026

DOI 10.21673/anadoluklin.1675424 Texte intégral en libre accèsSource : OpenAlex

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

Immunotherapy, 2026

DOI 10.1080/1750743x.2026.2722548 PMID 42683510 Texte intégral en libre accèsSource : OpenAlex

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Clinical Genitourinary Cancer, 2026

DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source : OpenAlex

Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

Clinics and Practice, 2026

DOI 10.3390/clinpract16090158 PMID 42783081 Texte intégral en libre accèsSource : OpenAlex

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020467 PMID 41598406 Texte intégral en libre accèsSource : ORCID

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

Future Oncology, 2025

DOI 10.1080/14796694.2025.2570637 PMID 41103123 Texte intégral en libre accèsSource : OpenAlex

KRAS Mutasyonu Saptanmayan Metastatik Kolorektal Kanserli Hastalarda Anti-EGFR Kullanımı-Ulusal Onco-Colon Çalışması Gerçek Yaşam Verleri

DergiPark (Istanbul University), 2025

Source : OpenAlex

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).

Journal of Clinical Oncology, 2025

DOI 10.1200/jco.2025.43.5_suppl.708 1 citation (OpenAlex) Source : OpenAlex

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of Oncology Pharmacy Practice, 2024

DOI 10.1177/10781552241241004 PMID 38613329 Texte intégral en libre accèsSource : OpenAlex

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e20512 Texte intégral en libre accèsSource : OpenAlex

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Bursa Uludag University - AVESIS, 2024

Source : OpenAlex

Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

Future Oncology, 2022

DOI 10.2217/fon-2021-1248 PMID 35081732 27 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data.

Journal of Clinical Oncology, 2022

DOI 10.1200/jco.2022.40.4_suppl.299 Source : OpenAlex

Küçük Molekül Tirozin Kinaz İnhibitörleri; RET Hedefli Tedaviler: Selpercatinib, Cabozantinib, Vandatenib

2021

Source : OpenAlex

Prostat Kanserinin Moleküler Biyolojisi

Turkiye Klinikleri Medical Oncology - Special Topics, 2017

Source : OpenAlex

Prostat Kanseri Tedavisinde Yeni Tedavi Yöntemleri

Turkiye Klinikleri Medical Oncology - Special Topics, 2017

Source : OpenAlex